Tumor heterogeneity should be considered when analyzing for TERT promoter mutations; punch biopsies of the highest-grade areas chosen by histological evaluation seem to yield the best results in capturing TERT promoter-mutated areas, but other methods such as digital droplet PCR (ddPCR) or targeted NGS could potentially have higher sensitivity. The gene discussed is TERT; the disease is neoplasm.